March 2022 Selected Grants
Below is a brief snapshot of some of the research grants awarded to Boston University faculty in March 2022. View previously selected grants, or a full summary of this month’s awards. For detailed information on research funding, visit Sponsored Research Reporting on the Research Support site.
CARB-X Global Antibacterial Accelerator
Total Anticipated
$ 10,000,000
Principal Investigator
Kevin M Outterson, School of Law
Sponsor
Wellcome Trust
Model Development and Medical Counter Measures (MCMS) for BSL-4 Agents in NHPS
Total Anticipated
$ 9,801,612
Principal Investigator
Anthony Griffiths, NEIDL
Sponsor
NIH/National Institute of Allergy and Infectious Diseases
Targeting the Genus Leishmania with Small Molecules
Total Anticipated
$ 3,774,320
Principal Investigator
Scott E Schaus, College of Arts & Sciences
Sponsor
NIH/National Institute of Allergy and Infectious Diseases
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Total Anticipated
$ 3,708703
Principal Investigator
Michael Stein, School of Public Health
Sponsor
NIH/National Institute on Drug Abuse
Ventricular-Vascular Coupling in the Elderly: Lifecourse Determinants, Trajectories and Prognostic Significance
Total Anticipated
$ 3,160,844
Principal Investigator
Vasan Ramachandran, School of Medicine
Sponsor
NIH/National Heart, Lung, and Blood Institute
A New Risk Assessment and Management Paradigm (NEWRAMP) in Electricity Markets
Total Anticipated
$ 3,000,000
Principal Investigator
Michael C Caramanis, College of Engineering
Sponsor
Department of Energy
Targeting Vascular Dysfunction to Promote Lung Repair and Fibrosis Resolution
Total Anticipated
$ 2,796,580
Principal Investigator
Giovanni Ligresti, School of Medicine
Sponsor
NIH/National Heart, Lung, and Blood Institute
Necrosis in Pulmonary TB Granulomas: Dynamics, Mechanisms, and Therapies
Total Anticipated
$ 2,788,080
Principal Investigator
Igor Kramnik, NEIDL
Sponsor
NIH/National Heart, Lung, and Blood Institute
Uncovering the Regulatory DNA Logic of the Drosophila Innate Immune Response
Total Anticipated
$ 999,999
Principal Investigator
Zeba Wunderlich, College of Arts & Sciences
Sponsor
National Science Foundation
China and the International Economic Order
Total Anticipated
$ 750,000
Principal Investigator
Kevin Gallagher, Global Development Policy Center
Sponsor
Carnegie Corporation of New York